Your are here: Home // Posts Tagged With drug
Neurocrine Boehringer Deal, A milestone in Diabetes Drug development
Neurocrine – Boehringer Deal, A milestone in Diabetes Drug development
Neurocrine Biosciences Inc (NBIX.O) has recently signed a deal with Boehringer Ingelheim which is a private German drug manufacturing company. Under the terms of the huge deal Neurocrine has assigned a task of developing drug candidates in order to treat Type 2 diabetes and other related symptoms.
According to Neurocirine,...
Otelixizumab is A Promising Drug to Treat Diabetes in only 6 Days
Otelixizumab is A Promising Drug to Treat Diabetes in only 6 Days
Have you ever thought about treating diabetes in a week with no insulin injection at all; absolutely not? But now it is possible through an amazing and major scientific breakthrough in which a drug named Otelixizumab can halt the symptoms of Type 1 diabetes within only six days if taken daily, according to the Daily Mail.
It will be...
FDA Decision to Reconsider Bydureon
FDA’s Decision to Reconsider ‘Bydureon’ – Another Chance for Diabetes Drug
After rejecting the approval application of diabetes drug ‘Bydureon’ in March 2010, FDA (Food and Drug Administration) has now decided to reconsider it, Alkermes Inc reported. This thing will provide ‘Bydureon’ another chance of getting approved by FDA to be used as reliable and useful drug in treating distressing...
MemoCharts Pharmacology – Diabetes Mellitus and Its Drug Therapy
Overall Rating:
Total Customer Reviews: (0)
Seller: Amazon
An integrated minireview of diabetes mellitus and its drug therapy, illustrated with visually appealing tables and diagrams. A quick visual aid for the course study and board review
Read More →
Byetta Commercial – Video
In light of the breaking news of the FDA Rejecting Byetta – here is a Byetta Commercial.
Byetta Commercial- Better Control of Your Diabetes
A TV commercial for a diabetes drug – Byetta, a kind of medicine for people with type 2 diabetes. It prompts improved blood glucose control (especially after meals) and weight loss in most patients.
Click here for more on Diabetes
Read More →
Diabetes Drug Byetta Rejected by FDA
The U.S. FDA denied approval of the diabetes drug Byetta, sold by Amylin Pharmaceuticals & Eli Lilly, the FDA reasoned in a letter sent to the 2 companies - more information is needed about the drug’s product label, risk-management plan and manufacturing process.
Amylin responded right away and it aims to submit its response to the FDA “in the next few weeks.” Despite...
